Pricing Log in Create free account

GeoVax Labs Inc. (GOVX) vs Oragenics, Inc. (OGEN)

GeoVax Labs Inc. and Oragenics, Inc. are both Biotechnology companies. GeoVax Labs Inc. and Oragenics, Inc. are of similar size ($1.6M and $1.6M). GeoVax Labs Inc. grew revenue faster over the last twelve months: 963.6% against −75.1%. Across the 13 metrics below, GeoVax Labs Inc. leads on 8 and Oragenics, Inc. on 5.

Valuation

Metric GOVX OGEN Biotechnology median
P/E n/m n/m 10.60
P/S 0.11 12.53 9.40
P/B 0.39 0.42 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 0.10 n/m 0.66
EV/Sales (0.33) 0.69 9.02
Earnings yield (9,086.67%) (982.63%) (32.88%)
Free cash flow yield (2,686.72%) (656.98%) (23.13%)

Profitability

Metric GOVX OGEN Biotechnology median
Gross margin 100.00% 19.89% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (891.59%) (1,307.07%) (51.96%)
Return on assets (408.79%) (264.23%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric GOVX OGEN Biotechnology median
Revenue growth (TTM) 963.56% (75.08%) 6.76%
EPS growth (last fiscal year) 81.41% 90.51% 29.88%
Revenue growth, 5-year CAGR 16.18% (50.98%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric GOVX OGEN Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 1.54 3.01 4.97
Net debt to EBITDA 0.14 0.98 1.01

Dividend

Metric GOVX OGEN Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric GOVX OGEN Biotechnology median
Market cap 1.60m 1.58m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack